You have been taking Stresam for a few weeks and have noticed that your appetite has changed, or that the scale shows a different number. This type of observation frequently appears in patient testimonials under étifoxine. Stresam is an anxiolytic prescribed for the psychological and physical manifestations of anxiety, but its side effect profile deserves attention, especially when trying to understand a possible link with weight variation.
Étifoxine and weight: what the official leaflet says (and doesn’t say)
The Stresam leaflet, updated by the ANSM in November 2024, does not mention weight loss or weight gain among the listed side effects. The effects listed focus on other target organs: liver, skin, digestive system.
Read also : What does Zalando mean? Discover the origin and meaning of the brand name
So where does this association between Stresam and weight variation come from? Mainly from patient testimonials. On experience feedback platforms like Meamedica, some users report loss of appetite or nausea while on treatment. These digestive symptoms can, indirectly, lead to weight loss. To better understand each side effect of Stresam on weight loss, it is necessary to distinguish what is due to a direct pharmacological effect from what results from temporary digestive discomfort.
No published clinical study demonstrates a causal link between étifoxine and weight loss. Observations from the field remain a qualitative signal, not formal proof.
See also : The Hidden Side of the Start-up World: Working Conditions and Realities
Stresam side effects: the risks that are actually documented
The side effect profile of Stresam is distinctly different from that of benzodiazepines. While the latter cause marked sedation and risk of dependence, étifoxine poses other types of problems.
Here are the side effects identified in the leaflet and regulatory alerts:
- Liver damage: cases of liver toxicity have led the ANSM to strengthen contraindications. Any history of liver issues must be reported to the prescribing doctor before starting treatment.
- Severe skin reactions: rashes, urticaria, and in rare cases, severe skin damage requiring immediate cessation of treatment and emergency consultation.
- Drowsiness at the start of treatment, which can affect driving and daily vigilance.
- Digestive disorders (nausea, gastric discomfort) sometimes reported from the first days of taking it, and which are precisely the indirect mechanism by which some patients lose weight.
A key point to remember: if you notice yellowing of the skin or eyes, or an unusual rash, consult a doctor without delay, even if the symptom seems mild.
Stresam maintained but regulated: what patients often overlook
The Prescrire review classifies étifoxine among medications to be avoided in care, which fuels frequent confusion. Many patients deduce that Stresam has been withdrawn from the market. This is not the case.
The ANSM and EMA opted for a different approach between 2023 and 2024: strengthening warnings without proceeding to withdrawal. Contraindications related to liver toxicity have been expanded, the maximum duration of treatment has been reiterated (a few days to a few weeks, not exceeding twelve weeks), and mentions regarding skin reactions have been reinforced.
This nuance changes the interpretation of the benefit/risk ratio. Stresam remains available, but its use is now more strictly regulated than a few years ago. A doctor prescribing it today does so within a more stringent regulatory framework.
Anxiolytic and weight: why Stresam does not act like a benzodiazepine
You may have read that some anxiolytics cause weight gain. This observation mainly concerns benzodiazepines, which cause significant sedation and can alter eating behavior due to a general slowdown in metabolism.
Étifoxine works differently. Its mechanism of action involves modulating GABA receptors via neurosteroids, without the heavy sedative effect of traditional benzodiazepines. Stresam does not cause physical dependence in the strict sense, which further distinguishes it from the profile of benzodiazepines.
The side effect profile of étifoxine is centered on the liver and skin, not on weight. If weight variation occurs, it is more likely related to nausea, a change in appetite due to anxiety itself, or a change in lifestyle during treatment.
What to do if you lose weight while on Stresam
Before attributing weight loss to the medication, ask yourself a simple question: have your eating habits or routines changed since starting treatment? Anxiety itself reduces appetite in many people, and simply starting treatment can sometimes alter daily routines.
If weight loss persists beyond a few days or is accompanied by recurring nausea, report it to your healthcare provider. They can assess whether the symptom is related to Stresam or another factor, and adjust the management accordingly.
Also keep in mind that the duration of treatment should not exceed twelve weeks. Beyond that, the therapeutic benefit is no longer demonstrated, and exposure to side effects becomes unnecessary. Regular medical follow-up throughout the duration of the prescription remains the best way to detect a side effect before it worsens.
Stresam is neither an appetite suppressant nor a medication associated with weight variations in official data. Testimonials exist, indirect mechanisms are plausible, but caution lies in not confusing correlation with causation, and always discussing it with a healthcare professional.